blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1670508

EP1670508 - COMPOSITIONS, METHODS AND KITS RELATING TO POXVIRUS SUBUNIT VACCINES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  30.08.2013
Database last updated on 30.07.2024
Most recent event   Tooltip17.07.2015Lapse of the patent in a contracting state
New state(s): HU, LU		published on 19.08.2015  [2015/34]
Applicant(s)For all designated states
TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
3160 Chestnut Street, Suite 200
Philadelphia, PA 19104 / US
For all designated states
NATIONAL INSTITUTES OF HEALTH
6011 Executive Boulevard, Suite 325
Rockville, MD 20852-3804 / US
[2006/25]
Inventor(s)01 / COHEN, Gary
41 Woodcroft Road
Havertown, PA 19083 / US
02 / EISENBERG, Roselyn J.
123 Glenwood Road
Haddonfield, NJ 08033 / US
03 / WHITBECK, John Charles
41 Twickenham Road
Glenside, PA 19038 / US
04 / ALDAZ-CARROL, Lydia
1717 Spuce Street, Apt 1F
Philadelphia, PA 19103 / US
05 / MOSS, Bernard
10301 Dickens Avenue
Bethesda, MD 20814 / US
06 / LUSTIG, Shlomo
14 Shear-Yashuv Street
Ramat Gan 52, 295-IL / IL
07 / FOGG, Christina
19600 White Saddle Drive
Germantown, MD 20874 / US
 [2006/25]
Representative(s)Grünecker Patent- und Rechtsanwälte PartG mbB
Leopoldstrasse 4
80802 München / DE
[N/P]
Former [2012/43]Grünecker, Kinkeldey, Stockmair & Schwanhäusser
Leopoldstrasse 4
80802 München / DE
Former [2006/25]Grünecker, Kinkeldey, Stockmair & Schwanhäusser Anwaltssozietät
Maximilianstrasse 58
80538 München / DE
Application number, filing date04775809.927.02.2004
[2006/25]
WO2004US05903
Priority number, dateUS20030451337P28.02.2003         Original published format: US 451337 P
[2006/25]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2005013918
Date:17.02.2005
Language:EN
[2005/07]
Type: A2 Application without search report 
No.:EP1670508
Date:21.06.2006
Language:EN
The application published by WIPO in one of the EPO official languages on 17.02.2005 takes the place of the publication of the European patent application.
[2006/25]
Type: B1 Patent specification 
No.:EP1670508
Date:24.10.2012
Language:EN
[2012/43]
Search report(s)International search report - published on:US29.12.2005
(Supplementary) European search report - dispatched on:EP25.07.2006
ClassificationIPC:C07K14/07, A61K39/285, A61K48/00, A61K39/275, A61K39/42, C07K16/08, C07K14/005
[2012/22]
CPC:
C07K14/005 (EP,US); A61K39/12 (EP,US); A61K39/285 (EP,US);
A61P37/04 (EP); C07K16/081 (EP,US); A61K2039/505 (EP,US);
A61K2039/53 (EP,US); C07K2317/76 (EP,US); C12N2710/24122 (EP,US);
C12N2710/24134 (EP,US) (-)
Former IPC [2006/25]A61K39/275, A61K39/285, A61K39/42, A61K48/00, C12N7/00, C12N15/39, C12N15/13, C07K16/08
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2006/25]
TitleGerman:ZUSAMMENSETZUNGEN, VERFAHREN UND KITS FÜR POCKENVIRUS-UNTEREINHEITS-VAKZINE[2006/25]
English:COMPOSITIONS, METHODS AND KITS RELATING TO POXVIRUS SUBUNIT VACCINES[2006/25]
French:COMPOSITIONS, METHODES ET KITS DE VACCINS A BASE DE SOUS-UNITE DE POXVIRUS[2006/25]
Entry into regional phase28.09.2005National basic fee paid 
28.09.2005Search fee paid 
28.09.2005Designation fee(s) paid 
28.09.2005Examination fee paid 
Examination procedure15.09.2004Request for preliminary examination filed
International Preliminary Examining Authority: US
28.09.2005Examination requested  [2006/25]
08.02.2006Amendment by applicant (claims and/or description)
12.11.2007Despatch of a communication from the examining division (Time limit: M06)
23.05.2008Reply to a communication from the examining division
13.11.2008Despatch of a communication from the examining division (Time limit: M06)
25.05.2009Reply to a communication from the examining division
09.02.2010Despatch of a communication from the examining division (Time limit: M04)
18.06.2010Reply to a communication from the examining division
13.04.2011Despatch of a communication from the examining division (Time limit: M03)
20.07.2011Reply to a communication from the examining division
05.09.2011Despatch of a communication from the examining division (Time limit: M02)
10.11.2011Reply to a communication from the examining division
22.12.2011Despatch of a communication from the examining division (Time limit: M03)
28.03.2012Reply to a communication from the examining division
15.06.2012Communication of intention to grant the patent
10.09.2012Fee for grant paid
10.09.2012Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  12.11.2007
Opposition(s)25.07.2013No opposition filed within time limit [2013/40]
Fees paidRenewal fee
23.02.2006Renewal fee patent year 03
28.03.2007Renewal fee patent year 04
25.02.2008Renewal fee patent year 05
26.02.2009Renewal fee patent year 06
25.03.2010Renewal fee patent year 07
23.02.2011Renewal fee patent year 08
26.03.2012Renewal fee patent year 09
Penalty fee
Additional fee for renewal fee
28.02.200704   M06   Fee paid on   28.03.2007
28.02.201007   M06   Fee paid on   25.03.2010
29.02.201209   M06   Fee paid on   26.03.2012
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU27.02.2004
AT24.10.2012
BE24.10.2012
CY24.10.2012
CZ24.10.2012
DK24.10.2012
EE24.10.2012
FI24.10.2012
IT24.10.2012
NL24.10.2012
RO24.10.2012
SE24.10.2012
SI24.10.2012
SK24.10.2012
TR24.10.2012
BG24.01.2013
GR25.01.2013
ES04.02.2013
PT25.02.2013
IE27.02.2013
LU27.02.2013
CH28.02.2013
LI28.02.2013
MC28.02.2013
[2015/34]
Former [2015/32]AT24.10.2012
BE24.10.2012
CY24.10.2012
CZ24.10.2012
DK24.10.2012
EE24.10.2012
FI24.10.2012
IT24.10.2012
NL24.10.2012
RO24.10.2012
SE24.10.2012
SI24.10.2012
SK24.10.2012
TR24.10.2012
BG24.01.2013
GR25.01.2013
ES04.02.2013
PT25.02.2013
IE27.02.2013
CH28.02.2013
LI28.02.2013
MC28.02.2013
Former [2014/07]AT24.10.2012
BE24.10.2012
CY24.10.2012
CZ24.10.2012
DK24.10.2012
EE24.10.2012
FI24.10.2012
IT24.10.2012
NL24.10.2012
RO24.10.2012
SE24.10.2012
SI24.10.2012
SK24.10.2012
BG24.01.2013
GR25.01.2013
ES04.02.2013
PT25.02.2013
IE27.02.2013
CH28.02.2013
LI28.02.2013
MC28.02.2013
Former [2013/48]AT24.10.2012
BE24.10.2012
CY24.10.2012
CZ24.10.2012
DK24.10.2012
EE24.10.2012
FI24.10.2012
IT24.10.2012
NL24.10.2012
RO24.10.2012
SE24.10.2012
SI24.10.2012
SK24.10.2012
BG24.01.2013
GR25.01.2013
ES04.02.2013
PT25.02.2013
CH28.02.2013
LI28.02.2013
MC28.02.2013
Former [2013/42]AT24.10.2012
BE24.10.2012
CY24.10.2012
CZ24.10.2012
DK24.10.2012
EE24.10.2012
FI24.10.2012
IT24.10.2012
NL24.10.2012
RO24.10.2012
SE24.10.2012
SI24.10.2012
SK24.10.2012
BG24.01.2013
GR25.01.2013
ES04.02.2013
PT25.02.2013
MC28.02.2013
Former [2013/37]AT24.10.2012
BE24.10.2012
CY24.10.2012
CZ24.10.2012
DK24.10.2012
EE24.10.2012
FI24.10.2012
IT24.10.2012
NL24.10.2012
RO24.10.2012
SE24.10.2012
SI24.10.2012
SK24.10.2012
BG24.01.2013
GR25.01.2013
ES04.02.2013
PT25.02.2013
Former [2013/35]AT24.10.2012
BE24.10.2012
CY24.10.2012
CZ24.10.2012
DK24.10.2012
EE24.10.2012
FI24.10.2012
NL24.10.2012
SE24.10.2012
SI24.10.2012
SK24.10.2012
BG24.01.2013
GR25.01.2013
ES04.02.2013
PT25.02.2013
Former [2013/34]AT24.10.2012
BE24.10.2012
CY24.10.2012
DK24.10.2012
FI24.10.2012
NL24.10.2012
SE24.10.2012
SI24.10.2012
BG24.01.2013
GR25.01.2013
ES04.02.2013
PT25.02.2013
Former [2013/31]AT24.10.2012
BE24.10.2012
CY24.10.2012
FI24.10.2012
NL24.10.2012
SE24.10.2012
SI24.10.2012
GR25.01.2013
ES04.02.2013
PT25.02.2013
Former [2013/28]BE24.10.2012
CY24.10.2012
FI24.10.2012
NL24.10.2012
SE24.10.2012
SI24.10.2012
GR25.01.2013
ES04.02.2013
PT25.02.2013
Former [2013/26]BE24.10.2012
CY24.10.2012
FI24.10.2012
NL24.10.2012
SE24.10.2012
SI24.10.2012
GR25.01.2013
ES04.02.2013
Former [2013/24]BE24.10.2012
CY24.10.2012
FI24.10.2012
NL24.10.2012
SE24.10.2012
GR25.01.2013
ES04.02.2013
Former [2013/23]CY24.10.2012
FI24.10.2012
NL24.10.2012
SE24.10.2012
ES04.02.2013
Former [2013/22]FI24.10.2012
NL24.10.2012
SE24.10.2012
ES04.02.2013
Former [2013/21]SE24.10.2012
Documents cited:Search[X]  - LAW MANSUN ET AL, "Antibody neutralization of the extracellular enveloped form of vaccinia virus", VIROLOGY, ACADEMIC PRESS,ORLANDO, US, (200102), vol. 280, no. 1, ISSN 0042-6822, pages 132 - 142, XP002175487 [X] 17-19,22,23,26,28-31,36-38,40-43 * the whole document *

DOI:   http://dx.doi.org/10.1006/viro.2000.0750
 [X]  - HOOPER J W ET AL, "DNA Vaccination with Vaccinia Virus L1R and A33R Genes Protects Mice against a Lethal Poxvirus Challenge", VIROLOGY, ACADEMIC PRESS,ORLANDO, US, (20000120), vol. 266, no. 2, ISSN 0042-6822, pages 329 - 339, XP004436171 [X] 1,14,17,18,23-31,36 * the whole document *

DOI:   http://dx.doi.org/10.1006/viro.1999.0096
 [X]  - RAMIREZ JUAN C ET AL, "Administration to mice of a monoclonal antibody that neutralizes the intracellular mature virus form of vaccinia virus limits virus replication efficiently under prophylactic and therapeutic conditions", JOURNAL OF GENERAL VIROLOGY, (200205), vol. 83, no. 5, ISSN 0022-1317, pages 1059 - 1067, XP002389473 [X] 17,18,23,28 * the whole document *
 [X]  - MATHEW E C ET AL, "A mutational analysis of the vaccinia virus B5R protein", JOURNAL OF GENERAL VIROLOGY, SOCIETY FOR GENERAL MICROBIOLOGY, SPENCERS WOOD, GB, (2001), vol. 82, no. 5, ISSN 0022-1317, pages 1199 - 1213, XP002988058 [X] 29-31,37,40 * page 1199 - page 1211; figure 1 *
 [X]  - DEL MAR LORENZO M ET AL, "Functional Analysis of Vaccinia Virus B5R Protein: Role of the Cytoplasmic Tail", VIROLOGY, ACADEMIC PRESS,ORLANDO, US, (19981220), vol. 252, no. 2, ISSN 0042-6822, pages 450 - 457, XP004445517 [X] 29-31,37,40 * page 450 - page 456 *

DOI:   http://dx.doi.org/10.1006/viro.1998.9483
 [X]  - HERRERA E ET AL, "Functional analysis of Vaccinia Virus B5R protein: essential role in virus envelopment is independent of a large portion of the extracellular domain", JOURNAL OF VIROLOGY, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, (199801), vol. 72, no. 1, ISSN 0022-538X, pages 294 - 302, XP002176446 [X] 29-31,37,40 * page 294 - page 302; figures 1,2 *
 [PX]  - FOGG CHRISTIANA ET AL, "Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions", JOURNAL OF VIROLOGY, (200410), vol. 78, no. 19, ISSN 0022-538X, pages 10230 - 10237, XP002389474 [PX] 1-16,24-47 * the whole document *

DOI:   http://dx.doi.org/10.1128/JVI.78.19.10230-10237.2004
 [PX]  - ALDAZ-CARROLL LYDIA ET AL, "Epitope-mapping studies define two major neutralization sites on the vaccinia virus extracellular enveloped virus glycoprotein B5R", JOURNAL OF VIROLOGY, (200505), vol. 79, no. 10, ISSN 0022-538X, pages 6260 - 6271, XP002389475 [PX] 17-20,23,26,28-31,36-38,40-43 * figures 1-10; table 1 *

DOI:   http://dx.doi.org/10.1128/JVI.79.10.6260-6271.2005
 [PX]  - CHEN ZHAOCHUN ET AL, "Chimpanzee/human mAbs to vaccinia virus B5 protein neutralize vaccinia and smallpox viruses and protect mice against vaccinia virus", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, (200602), vol. 103, no. 6, ISSN 0027-8424, pages 1882 - 1887, XP002389476 [PX] 17,18,23,26,28-31,36-38,40,41 * the whole document *

DOI:   http://dx.doi.org/10.1073/pnas.0510598103
International search[Y]WO0166138  (U S ARMY MEDICAL RES INST OF I [US], et al);
 [X]US6451309  (HOOPER JAY W [US], et al)
 [X]  - GALMICHE ET AL., "Neutralizing and Protective Antbodies Directed against Vaccina Virus Envelope Antigens.", VIROLOGY, (1999), vol. 254, pages 71 - 80, XP004440049

DOI:   http://dx.doi.org/10.1006/viro.1998.9516
 [Y]  - SANNA ET AL., "Directed selection of recombinant uman monoclonal antibodies to herpes simplex virus glycoproteins from phage display libraries", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, (199507), vol. 92, pages 6439 - 6443, XP002159770

DOI:   http://dx.doi.org/10.1073/pnas.92.14.6439
 [Y]  - LIANG ET AL., "Expression of a biologically active antiviral antibody using a sindbis virus vector system.", MOLECULAR IMUMNOLOGY, (1997), vol. 43, no. 12-13, pages 907 - 917, XP002972376

DOI:   http://dx.doi.org/10.1016/S0161-5890(97)00098-9
by applicantUS4082735
 US4082736
 US4101536
 US4185089
 US4235771
 US4406890
 US4606918
 US4053585
 US4261975
    - BREMAN ET AL., N. ENG. J. MED., (1998), vol. 339, pages 556 - 559
    - FRANZ ET AL., JAMA, (1997), vol. 278, pages 399 - 411
    - HENDERSON, SCIENCE, (1999), vol. 283, pages 1279 - 82
    - HENDERSON ET AL., CLIN. INFECT. DIS., (2001), vol. 33, pages 1057 - 1059
    - MEYER ET AL., J. GEN. VIROL., (1991), vol. 72, pages 1031 - 1038
    - MOSS, PROC. NATL. ACAD. SCI. U.S.A., (1996), vol. 93, pages 11341 - 1134
    - MOSS ET AL., Fields Virology, LIPPINCOTT-RAVEN, (1996), vol. 3, pages 2637 - 2671
    - SMITH ET AL., ADV. EXP. MED. BIOL., (1998), vol. 440, pages 395 - 414
    - SODEIK ET AL., TRENDS MICROBIOL., (2002), vol. 10, pages 15 - 24
    - HILLER ET AL., J. VIROL., (1985), vol. 55, pages 651 - 659
    - MOSS, PROC. NATL. ACAD. SCI. U.S.A., (1996), vol. 93, pages 1131 - 1134
    - LANE ET AL., JAMA, vol. 212, pages 441 - 4
    - LANE ET AL., NEW ENG. J. MED., (1969), vol. 281, pages 1201 - 1208
    - LANE ET AL., J. INFECT. DIS., (1970), vol. 122, pages 303 - 952,54
    - ROSENTHAL ET AL., EMERG. INFECT. DIS., (2001), vol. 7, pages 920 - 926
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.